Horizon Kinetics Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $498K | Sell |
10,239
-443
| -4% | -$21.5K | 0.01% | 241 |
|
|
2025
Q1 | $364K | Hold |
10,682
| – | – | ﹤0.01% | 257 |
|
|
2024
Q4 | $420K | Buy |
10,682
+443
| +4% | +$17.4K | 0.01% | 250 |
|
|
2024
Q3 | $481K | Sell |
10,239
-443
| -4% | -$20.8K | 0.01% | 236 |
|
|
2024
Q2 | $577K | Hold |
10,682
| – | – | 0.01% | 205 |
|
|
2024
Q1 | $728K | Hold |
10,682
| – | – | 0.01% | 185 |
|
|
2023
Q4 | $669K | Sell |
10,682
-443
| -4% | -$27.7K | 0.01% | 188 |
|
|
2023
Q3 | $505K | Hold |
11,125
| – | – | 0.01% | 210 |
|
|
2023
Q2 | $625K | Hold |
11,125
| – | – | 0.01% | 195 |
|
|
2023
Q1 | $503K | Buy |
11,125
+5,000
| +82% | +$226K | 0.01% | 210 |
|
|
2022
Q4 | $249K | Hold |
6,125
| – | – | ﹤0.01% | 262 |
|
|
2022
Q3 | $400K | Hold |
6,125
| – | – | 0.01% | 231 |
|
|
2022
Q2 | $372K | Hold |
6,125
| – | – | 0.01% | 242 |
|
|
2022
Q1 | $384K | Hold |
6,125
| – | – | 0.01% | 258 |
|
|
2021
Q4 | $464K | Hold |
6,125
| – | – | 0.01% | 246 |
|
|
2021
Q3 | $686K | Hold |
6,125
| – | – | 0.02% | 211 |
|
|
2021
Q2 | $992K | Hold |
6,125
| – | – | 0.02% | 176 |
|
|
2021
Q1 | $746K | Hold |
6,125
| – | – | 0.02% | 205 |
|
|
2020
Q4 | $938K | Hold |
6,125
| – | – | 0.03% | 182 |
|
|
2020
Q3 | $512K | Hold |
6,125
| – | – | 0.02% | 238 |
|
|
2020
Q2 | $450K | Buy |
6,125
+1,000
| +20% | +$73.5K | 0.02% | 246 |
|
|
2020
Q1 | $217K | Buy |
+5,125
| New | +$217K | 0.01% | 306 |
|